Warner Chilcott Settlement Underscores Risks in Manufacturer Relationships with Healthcare Providers and Reimbursement Support Programs

On October 29, 2015, the U.S. Department of Justice (DOJ) announced a global settlement with Warner Chilcott U.S. Sales LLC, a subsidiary of pharmaceutical manufacturer Warner Chilcott, based on conduct in violation of criminal healthcare fraud statutes and the civil False Claims Act.

Read more: Warner Chilcott Settlement Underscores Risks in Manufacturer Relationships with Healthcare Providers and Reimbursement Support Programs


Download PDF Share Back To Listing
Loading data